Insider Transactions in Q4 2022 at Better Therapeutics, Inc. (BTTX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Nov 30 2022	Mark Heinen Chief Financial Officer	BUY Grant, award, or other acquisition	Direct	15,723 +15.5%	$15,723 $1.24 P/Share
Nov 30 2022	Kristin Wynholds Chief Product Officer	BUY Grant, award, or other acquisition	Direct	3,781 +3.69%	$3,781 $1.24 P/Share

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Value

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

Operation

Value

Type

Receive news related to Better Therapeutics, Inc.